Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
about
The minor C-allele of rs2014355 in ACADS is associated with reduced insulin release following an oral glucose loadSIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationPantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted stateDisturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient miceMitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse modelsThey see a rat, we seek a cure for diseases: the current status of animal experimentation in medical practiceProtein targets for carbonylation by 4-hydroxy-2-nonenal in rat liver mitochondria.Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.Transcriptome Sequencing Reveals Large-Scale Changes in Axenic Aedes aegypti LarvaeKetone body metabolism and cardiovascular diseaseAcute alcohol exposure during mouse gastrulation alters lipid metabolism in placental and heart development: Folate prevention.Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis.Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse.Insulin-sensitizing and beneficial lipid-metabolic effects of the water-soluble melanin complex extracted from Inonotus obliquus.Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.Mice bearing Acads mutation display altered postingestive but not 5-s orosensory response to dietary fat.Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity.Acute inhibition of hepatic beta-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity.Increased mortality from influenza infection in long-chain acyl-CoA dehydrogenase knockout mice.A novel mouse model of X-linked cardiac hypertrophy.
P2860
Q21261492-407CC37B-359A-4DD3-A7D4-F1A873CFEF55Q28275010-38F56E75-E09D-41F7-AE4A-D8EA0B07E2CEQ28474360-F3A7D45B-D656-4D91-A5DB-85D134ACA9C7Q28593686-E0DF61E1-3891-43DC-AB7A-730EE7B7B894Q34163820-951CB957-F0A6-4D73-87F8-7D5D9B9E63E4Q34384270-3A704808-1A16-4F91-963E-D3EC10817631Q35422093-46D80228-4876-4DD7-919A-CAB16A5BA512Q35843679-CB386539-4A38-4AFE-A5D3-BBFB6D767377Q36242474-3F0A5C28-9FA3-4518-87D8-80DC7316E0CDQ36764435-4061D6A2-A709-48C8-8CE1-65736252C38CQ37391860-B9A43C8C-AF7F-4E1B-95A0-47DC2D053886Q37744748-B10658F9-8F74-48D2-BFAB-0C29522B1851Q37787094-60ECDA6E-CF1B-44A7-90A7-B8ADF0B8E281Q39155672-DD2BAB74-219C-421D-9FB1-D3A242E1157EQ41946553-9DC13277-EB34-45DC-98DD-4240ABD55C63Q42134737-2B699A8A-42EC-48B6-BABF-D2B427EE0D6DQ42805517-BE55AEDE-7347-4204-AA8C-09722BEC3FCAQ43072445-A6B507CD-AF09-423E-BA22-276732395F97Q44639121-63BE92CD-B6B2-4B02-BE3E-6EE1D35E3641Q44807440-A4B6F315-B138-4342-BF09-EF926A7309EDQ45270099-D5E4A4A8-E852-4341-B7E6-44D7111A48C8Q49848597-BA163322-DC64-4452-BC43-DFD41F4302A3Q51959136-447CCAE1-0F6B-4B2A-B59B-A115FA91B662
P2860
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@ast
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@en
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@nl
type
label
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@ast
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@en
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@nl
prefLabel
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@ast
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@en
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@nl
P2860
P356
P1433
P1476
Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
@en
P2093
A Michele Schuler
Philip A Wood
P2860
P356
10.1093/ILAR.43.2.57
P577
2002-01-01T00:00:00Z